Acupuncture with immunotherapy for advanced lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial tests if adding acupuncture to standard immunotherapy and chemotherapy helps people with advanced lung cancer. It is for those who have not had treatment before and whose tumors have low PD-L1 levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Able to get out and care for yourself (ECOG score 0 or 1)
- Advanced lung cancer that has spread (stage IIIB, IV, or extensive small cell)
- Tumor PD-L1 level less than 50%
- No EGFR, ALK, ROS1, or similar gene changes (for adenocarcinoma)
- Have not had any previous cancer treatment
- Fit the Traditional Chinese Medicine diagnosis of Qi Depression
- At least one measurable tumor (larger than 1 cm or lymph node ≥ 1.5 cm)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two different immunotherapy medicines (AK104 and tislelizumab) combined with chemotherapy as the first treatment for people with advanced lung cancer that hasn't spread to the brain and has low PD-L1. The goal is to see which combination works better and if it helps people live longer.
This trial tests whether adding electroacupuncture to a PD-1 inhibitor (a type of immunotherapy) can help people with advanced non-small cell lung cancer who have limited activity levels. It may improve treatment response and quality of life.
This trial explores whether adding electroacupuncture (a gentle needle treatment with mild electric pulses) to standard immunotherapy after lung cancer surgery can help prevent the cancer from coming back. It is designed for people with early-stage non-small cell lung cancer who have already had chemotherapy.
This trial tests whether adding electroacupuncture (a gentle, needle-based therapy) to a standard immunotherapy drug (PD-1 inhibitor) can help older adults with advanced lung cancer. It may improve treatment response and quality of life.
This study tests whether adding electroacupuncture at a specific point on the leg (called Zusanli) can help people with lung cancer who are getting chemotherapy and immunotherapy before surgery. It might reduce side effects and improve response to treatment.
This study tests whether adding electro-acupuncture (a gentle type of acupuncture with mild electrical pulses) to standard first-line immunotherapy and chemotherapy can help people with advanced non-small cell lung cancer. It aims to see if this combination improves quality of life and overall treatment outcomes.
Hear when a new Lung Cancers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.